OKYO Pharma reported total assets of $0.02B and total liabilities of $0.01B for the quarter ended Mar 2026. This balance sheet covers 11 quarters of results from Mar 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2021 | Mar2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Dec2024 | Mar2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash & EquivalentsCash & Equiv. | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B |
| Receivables - NetNet Receivables | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||
| Receivables - OtherOther Receivables | 43.37B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||
| Receivables | 43.37B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||
| Prepaid Assets | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||
| Current Assets | 6,986.69B | 4,295.37B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | ||
| Non-Current Assets | |||||||||||
| Property, Plant & Equipment (Net) | 6.06B | 5.22B | 7.22B | 0.00B | 3.35B | 0.00B | 2.04B | 0.00B | 6.31B | ||
| Other Non-Current Assets | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||
| Non-Current Assets | 104.64B | 5.22B | 7.22B | 5.14B | 3.35B | 2.16B | 2.04B | 1.18B | 6.31B | ||
| Assets | 0.01B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | ||
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payables | 1,673.15B | 1,306.15B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | ||
| Notes Payables | 47.04B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||
| Payables | 1,673.15B | 1,353.19B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | ||
| Short term Debt | 0.00B | 0.00B | |||||||||
| Current Leases | 34.15B | ||||||||||
| Total Current Liabilities | 1,707.30B | 1,353.19B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | ||
| Non-Current Liabilities | |||||||||||
| Operating Leases | 0.00B | ||||||||||
| Other Non-Current Liabilities | 861.21B | 53.41B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||
| Total Non-Current Liabilities | -861.21B | -53.41B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | ||
| Total Liabilities | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | ||
| Shareholder's Equity | |||||||||||
| Total Debt | 47.04B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||
| Common Equity | 0.01B | 0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | 0.01B | ||
| Liabilities and Shareholders Equity | 0.01B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | ||
| Retained Earnings | -106003.75B | -112426.03B | -0.13B | -0.13B | -0.14B | -0.15B | -0.14B | -0.15B | -0.15B |